She will serve on the company’s Audit Committee, a position that went into effect March 30. She has more than 20 years of experience as a healthcare executive and has overseen the revenue growth at AmSurg from $30 million to more than $1.62 billion.
Ms. Gulmi also helped orchestrate AmSurg’s Sheridan healthcare acquisition, valued at $2.35 billion.
Air Methods is an air medical transportation company.
More articles on healthcare:
Global mHealth market to see growth of 40% in 6 years—4 things to know
The Joint Commission proposes requirements for optional TJR certification program
Outlook for the ASC space: How to position for the next big opportunities
